Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database

Clinical Therapeutics

Volumn 30, Issue 8, 2008, Pages 1558-1563

  Jackson II, Kenneth C ^a   Sheng, Xiaoming ^b   Nelson, Richard E ^c   Keskinaslan, Abdulkadir ^d   Brixner, Diana I ^c  

^a PACIFIC UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

adherence; antihypertensives; combination therapy; compliance; fixed dose combinations; hydrochlorothiazide; hypertension; medication possession ratio (MPR); valsartan

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS VALSARTAN; AMLODIPINE PLUS VALSARTAN; ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; COMORBIDITY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG MIXTURE; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION POSSESSION RATIO; PARAMETER; PATIENT COMPLIANCE; PILL; POLYPHARMACY; REFERENCE DATABASE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PATIENT COMPLIANCE; TETRAZOLES; UNITED STATES; VALINE;

EID: 51549097523     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.08.010     Document Type: Article

References (20)

1. Oparil S., and Calhoun D.A. Managing the patient with hard-to-control hypertension. Am Fam Physician 57 (1998) 1007-1014
2. Oparil S., and Calhoun D.A. Managing the patient with hard-to-control hypertension. Am Fam Physician 57 (1998) 1019-1020
3. Gerth W.C. Compliance and persistence with newer antihypertensive agents. Curr Hypertens Rep. 4 (2002) 424-433
4. Van Wijk B.L., Klungel O.H., Heerdink E.R., and de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 23 (2005) 2101-2107
5. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care. 40 (2002) 794-811
6. Yiannakopoulou E., Papadopulos J.S., Cokkinos D.V., and Mountokalakis T.D. Adherence to antihypertensive treatment: A critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 12 (2005) 243-249
7. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 19 (2006) 1190-1196
8. Sokol M.C., McGuigan K.A., Verbrugge R.R., and Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 43 (2005) 521-530
9. Cramer J. Medicine partnerships. Heart 89 Suppl 2 (2003) ii19-ii21 discussion ii35-ii37
10. McCombs J.S., Nichol M.B., Newman C.M., and Sclar D.A. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 32 (1994) 214-226
11. Rizzo J.A., Abbott III T.A., and Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ. 5 (1996) 249-265
12. Muszbek N., Brixner D., Benedict A., et al. The economic consequences of noncompliance in cardiovascular disease and related conditions: A literature review. Int J Clin Pract. 62 (2008) 338-351
13. Chapman R.H., Benner J.S., Petrilla A.A., et al. Predictors of adherence with antihypertensive and lipidlowering therapy. Arch Intern Med. 165 (2005) 1147-1152
14. Taylor A.A., and Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail. 9 (2003) 324-332
15. Gerbino P.P., and Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm. 64 (2007) 1279-1283
16. Bangalore S., Kamalakkannan G., Parkar S., and Messerli F.H. Fixed-dose combinations improve medication compliance: A meta-analysis. Am J Med. 120 (2007) 713-719
17. LaFleur J., Thompson C.J., Joish V.N., et al. Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin. Ann Pharmacother. 40 (2006) 1274-1279
18. Grant R.W., O'Leary K.M., Weilburg J.B., et al. Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med. 164 (2004) 2343-2348
19. Pedan A., Varasteh L., and Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm. 13 (2007) 487-496
20. Shalansky S.J., and Levy A.R. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 36 (2002) 1532-1539